Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 30 August 2011
Vol. 4, Issue 188, p. ra56
[DOI: 10.1126/scisignal.2001754]

RESEARCH ARTICLES

Editor's Summary

Building the Building Blocks
Ribosomes translate mRNA into protein, and the activity of signaling pathways that promote ribosome formation (or biogenesis) is often increased in cancer cells, which have high rates of protein synthesis and cell growth. Thus, each step of ribosome biogenesis can limit cell growth, including the synthesis of ribosomal RNA (rRNA), which encodes the RNA components of the ribosome. Chan et al. found that the kinase AKT, which is frequently activated in cancer cells and was previously implicated in promoting protein translation, also promotes rRNA synthesis. Cells with increased AKT activity showed increased rRNA abundance and more ribosomes. The transcription factor c-MYC is required for ribosome biogenesis, and the gene encoding c-MYC is frequently mutated in tumors. The ability of c-MYC to promote ribosome biogenesis and cell growth in a mouse model of lymphoma was attenuated by an AKT inhibitor. These results suggest that reducing ribosome biogenesis may in part underlie the therapeutic efficacy of anticancer drugs that target AKT signaling.

Citation: J. C. Chan, K. M. Hannan, K. Riddell, P. Y. Ng, A. Peck, R. S. Lee, S. Hung, M. V. Astle, M. Bywater, M. Wall, G. Poortinga, K. Jastrzebski, K. E. Sheppard, B. A. Hemmings, M. N. Hall, R. W. Johnstone, G. A. McArthur, R. D. Hannan, R. B. Pearson, AKT Promotes rRNA Synthesis and Cooperates with c-MYC to Stimulate Ribosome Biogenesis in Cancer. Sci. Signal. 4, ra56 (2011).

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
HSPC111 Governs Breast Cancer Growth by Regulating Ribosomal Biogenesis.
C. Zhang, C. Yin, L. Wang, S. Zhang, Y. Qian, J. Ma, Z. Zhang, Y. Xu, and S. Liu (2014)
Mol. Cancer Res. 12, 583-594
   Abstract »    Full Text »    PDF »
Akt activation enhances ribosomal RNA synthesis through casein kinase II and TIF-IA.
L. X. T. Nguyen and B. S. Mitchell (2013)
PNAS 110, 20681-20686
   Abstract »    Full Text »    PDF »
Tight Coordination of Protein Translation and HSF1 Activation Supports the Anabolic Malignant State.
S. Santagata, M. L. Mendillo, Y.-c. Tang, A. Subramanian, C. C. Perley, S. P. Roche, B. Wong, R. Narayan, H. Kwon, M. Koeva, et al. (2013)
Science 341, 1238303
   Abstract »    Full Text »    PDF »
Hunk negatively regulates c-myc to promote Akt-mediated cell survival and mammary tumorigenesis induced by loss of Pten.
E. S. Yeh, G. K. Belka, A. E. Vernon, C.-C. Chen, J. J. Jung, and L. A. Chodosh (2013)
PNAS 110, 6103-6108
   Abstract »    Full Text »    PDF »
Translational Control in Cancer Etiology.
D. Ruggero (2013)
Cold Spring Harb Perspect Biol 5, a012336
   Abstract »    Full Text »    PDF »
Revisiting the Nucleolus: From Marker to Dynamic Integrator of Cancer Signaling.
D. Ruggero (2012)
Science Signaling 5, pe38
   Abstract »    Full Text »    PDF »
Translation Regulation as a Therapeutic Target in Cancer.
M. Grzmil and B. A. Hemmings (2012)
Cancer Res. 72, 3891-3900
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882